Navigation Links
RNA Nanotechnology To Rescue Cancer Patients In Future

Scientists have now developed tiny delivery vehicles that can carry anticancer therapeutic agents directly into infected cells, using strands of genetic material constructed through nanotechnology, offering a potential wealth // of new treatments for chronic diseases. This emerging branch of science is called nanomedicine.

These delivery agents are called nanoparticles, and are assembled from three short pieces of ribonucleic acid. The microscopic particles are designed in such a way that they possess both the right size to gain entry into cells and also the right structure to carry other therapeutic strands of RNA inside with them, where they are able to halt viral growth or cancer's progress.

RNA or ribonucleic acid has immense promise as a therapeutic agent against cancer, and furthermore, it might be possible to deliver multiple therapeutic agents to the cell at the same time, adding versatility and potential to the medical valve of the nanoparticles.

RNA molecules come in many variant forms, and the sort that the team mimicked from the phi29 virus – called pRNA – also can be linked to other types of RNA to form longer, hybrid strands with properties the researchers could assign. The nanoparticles have been created by linking together different kinds of RNA, after the successful manipulation of these stringy molecules into different shapes, including rods, triangles and arrays.

An effective agent against cancer needs to accomplish several tasks. It needs first to recognize the cancer cell and gain access to its interior, and then it needs to destroy it. It is also important for the molecule to act like a tracer that can provide valuable information regarding the location and the outcome of treatment.

Particles pass through cell membranes into the cell's interior, and the body has a hard time retaining particles smaller than 10 nanometers. But the tiny triangles fit, and they worked well enough to interrupt the grow th of human breast cancer cells and leukemia model lymphocytes in laboratory experiments.

"One characteristic of cancer cells is that they do not stop growing, which is one reason tumors develop," said Guo, a senior researcher. "Once inside, the siRNA essentially instructs the cells to 'stop not stopping.' The nanoparticles had done their work on the breast cancer cell cultures within a few days."

"The results are very promising, but we still have several hurdles to jump before we can test this therapy on people," Guo said. "First and foremost, we must ensure that it is as safe as we think it is. Some RNA can be toxic to noncancerous cells as well, and though our nanoparticles appear to go straight to the cancer cells where we want them to go, we have to be sure they do not go anywhere else before we can inject them into a living person.

Nanotechnology is beginning to pay off here in that it may have provided us with a solution to the problem. We hope to enhance the work we have done so far and refine it for human trials."


'"/>




Related medicine news :

1. CoQ10 bioavailability increased by Nanotechnology
2. Nanotechnology Revolution To Be Spearheaded By European Union
3. Scientists Consider About New Technology Called Nanotechnology
4. Potential Benefits Of New Nanotechnology
5. Nanotechnology Promises Huge Medical Benefits
6. Nanotechnology at its best: Nanomotors And Mechanical Nanoswitches
7. Nanotechnology Could Revolutionize Cardiac Treatment
8. Anti-Sense Drugs and Nanotechnology Offer New Hope In Cancer Fight
9. Nanotechnology – to detect and treat ovarian cance
10. Nanotechnology Used For Detecting Viruses
11. India, China Trying to Fight Disease With Nanotechnology
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/16/2017)... (PRWEB) , ... January 16, 2017 , ... ... the availability of the newly updated International Audit Protocol Consortium (IAPC) EHS audit ... audit protocols to understand the scope of their EHS regulatory obligations and rapidly ...
(Date:1/16/2017)... Grants Pass, OR (PRWEB) , ... January 16, ... ... Kent Heckenlively, author, editor, attorney, science teacher, http://www.ageofautism.com/legal , Sharon Kleyne, ... and attorney Kent Heckenlively to her nationally syndicated radio program, The Sharon Kleyne ...
(Date:1/16/2017)... ... January 16, 2017 , ... One thing common to all ... but to test for, as well. The money spent screening for and treating cancer ... the U.S. screen patients for cancer more than in any other country that has ...
(Date:1/16/2017)... ... January 16, 2017 , ... NexTec Group has been selected ... 100 organizations honored for their accomplishments in the field of midmarket financial software. , ... and recognition, and innovation. Selection is not based on revenue and those firms chosen ...
(Date:1/15/2017)... NC (PRWEB) , ... January 15, 2017 , ... Whole Health Supply, LLC is announcing ... . There are also new avenues for purchase. , The 2017 edition has wide ... cause issues for the older boomers as well as diabetics. This handle is reinforced for ...
Breaking Medicine News(10 mins):
(Date:1/17/2017)... YORK , Jan. 17, 2017 Immune ... stage biopharmaceutical company, announced today that it will hold ... Symposium on Acute Leukemias (ISAL) XVI in ... is entitled:  "Reinforcing the Efficacy of Immunotherapy for the ... take place on Monday February 20 th , 2017 from ...
(Date:1/17/2017)... , Jan. 17, 2017  Zimmer Biomet Holdings, Inc. ... healthcare , today announced that it has ... strength of the Zimmer Biomet management team. Effective ... will assume the position of President, Americas and ... Delp previously served as Zimmer Biomet,s Vice President ...
(Date:1/17/2017)... LONDON , January 17, 2017 ... poised to potentially earn millions in revenue with the ... prevent massive numbers of strokes with a simple test ... Biotech Companies with latest developments in the markets today ... PLC (NYSE: AZN ), Cancer Genetics, Inc. ...
Breaking Medicine Technology: